Stock listing
Frankfurt:7R8 Replimune Group, Inc. Aktie
German listing (Frankfurt) of Replimune Group, Inc. · home listing NASDAQ:REPL
Follow Replimune Group, Inc. into a list and get an email when it puts out news.
Share price · FWB:7R8
€14.79 EUR +3.64 (+32.7%)
Close on Oct 30, 2026
- Day range
- €14.79 – €15.82 EUROct 30, 2026
- Market cap
- €1.39B EURAt the close on Oct 30, 2026 · price × 94.22M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:REPL · Home | $17.61 USD | +0.22 (+1.3%) | 3,851,718 | $17.49 | $18.27 | $16.64 | $17.39 | Close on Oct 30, 2026 |
| Frankfurt:7R8 | €14.79 EUR | +3.645 (+32.7%) | — | €15.26 | €15.82 | €14.79 | €11.15 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:7R8
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 28, 2026
Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update
Latest earnings call · Oct 28, 2026
Replimune Group (NASDAQ:REPL) Q2 2027 Earnings Call
Replay and transcript
Latest deck · Aug 6, 2026
Corporate Update (August 2026)
Corporate update · 30 slides
Calls
Replays
Replimune Group (NASDAQ:REPL) Q2 2027 Earnings Call
Wed, Oct 28, 2026 · 8:00 AM ET
Watch TranscriptReplimune Group (NASDAQ:REPL) Q4 2025 Earnings Call
Thu, May 22, 2025 · 8:00 AM ET
Watch Transcript
Latest news
Financings
Public offering of common stock
Aug 14, 2026
Closed: US$150M raised · US$12.06 a share · Leerink Partners +2
Dealers: Leerink Partners (co-lead), J.P. Morgan (co-lead), Cantor (co-lead)
Use of proceeds: Support the commercial launch of TUDRIQEV and the ongoing IGNYTE-3 confirmatory trial
Decks
Corporate Update (August 2026)
Corporate update · 30 slides · Aug 6, 2026
Technical Presentation (July 2026)
Technical · 64 slides · Jul 30, 2026
JPM Healthcare Conference 2026
Conference · 30 slides · Jan 14, 2026
Technical Presentation (June 2024)
Technical · 27 slides · Jun 6, 2024
Replimune Group, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 139 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 2 calls with a replay · 2 with a transcript · latest Oct 28, 2026
- Decks
- 9 decks · latest Aug 6, 2026
Where Replimune Group, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:REPL · Home listing | NASDAQ | United States | USD |
| gettex:7R8 | gettex | Germany | EUR |
| LS Exchange:A2JQN1 | LS Exchange | Germany | EUR |
| BOATS:REPL | BOATS | United States | USD |
| Lang & Schwarz:A2JQN1 | Lang & Schwarz | Germany | EUR |
| Stuttgart:7R8 | Stuttgart | Germany | EUR |
| Tradegate:7R8 | Tradegate | Germany | EUR |
| Frankfurt:7R8 · This page | Frankfurt | Germany | EUR |
| Hamburg:7R8 | Hamburg | Germany | EUR |
| Munich:7R8 | Munich | Germany | EUR |
| Dusseldorf:7R8 | Dusseldorf | Germany | EUR |
Log in to ask 6ix AI your own questions about Replimune Group, Inc.